Ole Vahlgren (born 1963) is Board member since 2020. He is also Member of the Audit Committee.
His work experience includes the position as CEO of AJ Vaccines A/S. He has also more than 25 years experience from business development and strategy work in international and global pharmaceutical companies such as H. Lundbeck and Otsuka.
Ole holds a MSc from Technical University of Denmark, Copenhagen. MBA from Business School of Copenhagen.
Other current appointments: Board member of Go-PEN Aps and Blue Cell Therapeutics.
Holdings: 10,000 shares.
Independent in relation to the company and its management and the company’s major shareholders.